Exposure to the iron chelator deferoxamine (DFO) significantly reduced the stemness-related transcription factors Nanog and Sox2, mammosphere formation, and the CD44+/CD133+ and ALDH+ SK-OV-3 ovarian cancer cell subpopulations [112]. This evidence concerns the gene CD44 and ovarian carcinoma.